Shenglin Ma - Concepedia

Author

Shenglin Ma

Hangzhou First People's Hospital

Also Known As

MA, Shenglin, Ma, Shenglin, Sheng-Lin Ma, Sheng-lin MA, Sheng-lin Ma, Shenglin Ma, Xinmeng Li, Yiping Zhang

120

Publications

Citations

H-Index

Concepts

All Affiliations

Hangzhou First People's Hospital Zhejiang Cancer Hospital Hangzhou Cancer Hospital Zhejiang University Nanjing Medical University

About

Shenglin Ma is an author at Hangzhou First People's Hospital specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	3K
2	Health Sciences	5	5	453
3	Engineering	4	4	102
4	Biomedical Engineering	4	4	102
5	Public Health	1	1	43

Shenglin Ma

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen, The Lancet Platinum–etoposide Versus Platinum–etoposideMedicinePharmacologyImmune Checkpoint InhibitorFirst-line Treatment	2019	2.1K
Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial Li Zhang, Shenglin Ma, Xiangqun Song, The Lancet Oncology MedicineClinical TrialsMaintenance TherapyImmune Checkpoint InhibitorPharmacotherapy	2012	225
Finger-inspired rigid-soft hybrid tactile sensor with superior sensitivity at high frequency Jinhui Zhang, Haimin Yao, Jiaying Mo, Nature Communications	2022	220
Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population Shenglin Ma, Yaping Xu, Qinghua Deng, Lung Cancer Health SciencesRadiation TherapyMedicineBrain MetastasisBronchial Neoplasm	2008	130
Genetic polymorphisms and treatment response in advanced non-small cell lung cancer Dan Su, Shenglin Ma, Peng Liu, Lung Cancer Genetic PolymorphismsMedicineGeneticsHuman PolymorphismTreatment Response	2007	106
SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer Jingjing Zhang, Qiong Wu, Lucheng Zhu, Cancer Letters Tumor BiologyGenome InstabilitySerine Proteinase InhibitorOncogenic AgentMedicine	2021	86
Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel Dan Su, Stephanie M. Smith, Mario Preti, Cancer	2009	76
Expression and Function Analysis of Mitotic Checkpoint Genes Identifies TTK as a Potential Therapeutic Target for Human Hepatocellular Carcinoma Xiaodong Liang, Yuechu Dai, Zhaoyun Li, PLoS ONE Potential Therapeutic TargetTumor BiologyFunction AnalysisHcc SpecimensHcc Tissues	2014	46
Polydopamine nanomotors loaded indocyanine green and ferric ion for photothermal and photodynamic synergistic therapy of tumor Jinzha Zhang, Ke Zhang, Yijie Hao, Journal of Colloid and Interface Science Polydopamine NanomotorsNanomedicineFerric IonEngineeringPhotochemistry	2022	44
Tail risk contagion and multiscale spillovers in the green finance index and large US technology stocks Hongjun Zeng, Mohammad Zoynul Abedin, Brian M. Lucey, International Review of Financial Analysis	2024	44

Page 1